BioCentury | Jun 22, 2020
Emerging Company Profile

Prosit Sole: chimeric proteins for rare disease

...to generate libraries of candidate therapies with optimized potency, pharmacodynamics, shelf life and protein expression. Prosit Sole...
...alterations, such as single mutations, may not be enough to avoid infringing upon previous patents. Prosit Sole Biotechnology Co. Ltd....
...file a U.S. IND for chronic norovirus infection in 3Q20. Orphanon Inc., a subsidiary of Prosit Sole...
Items per page:
1 - 1 of 1
BioCentury | Jun 22, 2020
Emerging Company Profile

Prosit Sole: chimeric proteins for rare disease

...to generate libraries of candidate therapies with optimized potency, pharmacodynamics, shelf life and protein expression. Prosit Sole...
...alterations, such as single mutations, may not be enough to avoid infringing upon previous patents. Prosit Sole Biotechnology Co. Ltd....
...file a U.S. IND for chronic norovirus infection in 3Q20. Orphanon Inc., a subsidiary of Prosit Sole...
Items per page:
1 - 1 of 1